Cdkn1c Boosts the Development of Brown Adipose Tissue in a Murine Model of Silver Russell Syndrome

The accurate diagnosis and clinical management of the growth restriction disorder Silver Russell Syndrome (SRS) has confounded researchers and clinicians for many years due to the myriad of genetic and epigenetic alterations reported in these patients and the lack of suitable animal models to test the contribution of specific gene alterations. Some genetic alterations suggest a role for increased dosage of the imprinted CYCLIN DEPENDENT KINASE INHIBITOR 1C (CDKN1C) gene, often mutated in IMAGe Syndrome and Beckwith-Wiedemann Syndrome (BWS). Cdkn1c encodes a potent negative regulator of fetal growth that also regulates placental development, consistent with a proposed role for CDKN1C in these complex childhood growth disorders. Here, we report that a mouse modelling the rare microduplications present in some SRS patients exhibited phenotypes including low birth weight with relative head sparing, neonatal hypoglycemia, absence of catch-up growth and significantly reduced adiposity as adults, all defining features of SRS. Further investigation revealed the presence of substantially more brown adipose tissue in very young mice, of both the classical or canonical type exemplified by interscapular-type brown fat depot in mice (iBAT) and a second type of non-classic BAT that develops postnatally within white adipose tissue (WAT), genetically attributable to a double dose of Cdkn1c in vivo and ex-vivo. Conversely, loss-of-function of Cdkn1c resulted in the complete developmental failure of the brown adipocyte lineage with a loss of markers of both brown adipose fate and function. We further show that Cdkn1c is required for post-transcriptional accumulation of the brown fat determinant PR domain containing 16 (PRDM16) and that CDKN1C and PRDM16 co-localise to the nucleus of rare label-retaining cell within iBAT. This study reveals a key requirement for Cdkn1c in the early development of the brown adipose lineages. Importantly, active BAT consumes high amounts of energy to generate body heat, providing a valid explanation for the persistence of thinness in our model and supporting a major role for elevated CDKN1C in SRS.

[1]  W. van Workum,et al.  Paternally Inherited IGF2 Mutation and Growth Restriction. , 2015, The New England journal of medicine.

[2]  Y. Kido,et al.  Paternal allelic mutation at the Kcnq1 locus reduces pancreatic β-cell mass by epigenetic modification of Cdkn1c , 2015, Proceedings of the National Academy of Sciences.

[3]  T. Ogata,et al.  Silver–Russell syndrome without body asymmetry in three patients with duplications of maternally derived chromosome 11p15 involving CDKN1C , 2014, Journal of Human Genetics.

[4]  P. Lapunzina,et al.  CDKN1C mutations: two sides of the same coin. , 2014, Trends in molecular medicine.

[5]  Michael H. Guo,et al.  A novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetes. , 2014, The Journal of clinical endocrinology and metabolism.

[6]  L. Lefebvre,et al.  Beckwith–Wiedemann and Silver–Russell syndromes: opposite developmental imbalances in imprinted regulators of placental function and embryonic growth , 2013, Clinical genetics.

[7]  M. Nakanishi,et al.  Increased Protein Stability of CDKN1C Causes a Gain-of-Function Phenotype in Patients with IMAGe Syndrome , 2013, PloS one.

[8]  P. Seale,et al.  Brown and beige fat: development, function and therapeutic potential , 2013, Nature Medicine.

[9]  A. Faussat,et al.  CDKN1C mutation affecting the PCNA-binding domain as a cause of familial Russell Silver syndrome , 2013, Journal of Medical Genetics.

[10]  Akinobu Matsumoto,et al.  p57 controls adult neural stem cell quiescence and modulates the pace of lifelong neurogenesis , 2013, The EMBO journal.

[11]  H. Hartung,et al.  p57kip2 regulates glial fate decision in adult neural stem cells , 2012, Development.

[12]  B. Spiegelman,et al.  Beige Adipocytes Are a Distinct Type of Thermogenic Fat Cell in Mouse and Human , 2012, Cell.

[13]  S. Nelson,et al.  Mutations in the PCNA-binding domain of CDKN1C cause IMAGE Syndrome , 2012, Nature Genetics.

[14]  S. Ring,et al.  DNA Methylation Patterns in Cord Blood DNA and Body Size in Childhood , 2012, PloS one.

[15]  C. Kim,et al.  Microduplication of the ICR2 domain at chromosome 11p15 and familial Silver–Russell syndrome , 2011, American journal of medical genetics. Part A.

[16]  C. Kanduri,et al.  The KCNQ1OT1 imprinting control region and non-coding RNA: new properties derived from the study of Beckwith–Wiedemann syndrome and Silver–Russell syndrome cases , 2011, Human molecular genetics.

[17]  Akinobu Matsumoto,et al.  p57 is required for quiescence and maintenance of adult hematopoietic stem cells. , 2011, Cell stem cell.

[18]  Zachary D. Smith,et al.  Lung stem cell self-renewal relies on BMI1-dependent control of expression at imprinted loci. , 2011, Cell stem cell.

[19]  E. Dicicco-Bloom,et al.  The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors. , 2011, Cerebral cortex.

[20]  Simon James Tunster,et al.  Fetal overgrowth in the Cdkn1c mouse model of Beckwith-Wiedemann syndrome , 2011, Disease Models & Mechanisms.

[21]  I. Lemischka,et al.  Prdm16 is a physiologic regulator of hematopoietic stem cells. , 2011, Blood.

[22]  E. Fuchs,et al.  Ferreting out stem cells from their niches , 2011, Nature Cell Biology.

[23]  E. Wakeling Silver–Russell syndrome , 2011, Archives of Disease in Childhood.

[24]  B. Spiegelman,et al.  Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice. , 2011, The Journal of clinical investigation.

[25]  B. Levi,et al.  Prdm16 promotes stem cell maintenance in multiple tissues, partly by regulating oxidative stress , 2010, Nature Cell Biology.

[26]  I. Temple,et al.  Epigenotype–phenotype correlations in Silver–Russell syndrome , 2010, Journal of Medical Genetics.

[27]  M. Cubellis,et al.  Silver-Russell Syndrome and Beckwith-Wiedemann Syndrome Phenotypes Associated with 11p Duplication in a Single Family , 2010, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[28]  M. Baudis,et al.  Chromosome 11p15 duplication in Silver‐Russell syndrome due to a maternally inherited translocation t(11;15) , 2010, American journal of medical genetics. Part A.

[29]  P. Seale,et al.  Beige Can Be Slimming , 2010, Science.

[30]  Jong-Yeon Shin,et al.  Autonomous silencing of the imprinted Cdkn1c gene in stem cells , 2010, Epigenetics.

[31]  Jan Nedergaard,et al.  Chronic Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation of Epididymally Derived White Adipocyte Cultures Reveals a Population of Thermogenically Competent, UCP1-containing Adipocytes Molecularly Distinct from Classic Brown Adipocytes* , 2009, The Journal of Biological Chemistry.

[32]  S. Enerbäck The origins of brown adipose tissue. , 2009, The New England journal of medicine.

[33]  K. Ottersbach,et al.  Identification of novel regulators of hematopoietic stem cell development through refinement of stem cell localization and expression profiling. , 2009, Blood.

[34]  B. Tycko,et al.  The Imprinted Phlda2 Gene Regulates Extraembryonic Energy Stores , 2009, Molecular and Cellular Biology.

[35]  S. Snijder,et al.  Phenotypic discordance upon paternal or maternal transmission of duplications of the 11p15 imprinted regions. , 2009, European journal of medical genetics.

[36]  E. R. Andersson,et al.  p57Kip2 is a repressor of Mash1 activity and neuronal differentiation in neural stem cells , 2009, Cell Death and Differentiation.

[37]  R. D'Hooge,et al.  Cold stimulates the behavioral response to hypoxia in newborn mice. , 2009, American journal of physiology. Regulatory, integrative and comparative physiology.

[38]  T. Eggermann Silver-Russell and Beckwith-Wiedemann Syndromes: Opposite (Epi)Mutations in 11p15 Result in Opposite Clinical Pictures , 2009, Hormone Research in Paediatrics.

[39]  S. Bilodeau,et al.  Distinct Developmental Roles of Cell Cycle Inhibitors p57Kip2 and p27Kip1 Distinguish Pituitary Progenitor Cell Cycle Exit from Cell Cycle Reentry of Differentiated Cells , 2009, Molecular and Cellular Biology.

[40]  S. South,et al.  Co‐occurrence of 4p16.3 deletions with both paternal and maternal duplications of 11p15: Modification of the Wolf–Hirschhorn syndrome phenotype by genetic alterations predicted to result in either a Beckwith–Wiedemann or Russell–Silver phenotype , 2008, American journal of medical genetics. Part A.

[41]  B. Spiegelman,et al.  PRDM16 controls a brown fat/skeletal muscle switch , 2008, Nature.

[42]  D. Haig Huddling: Brown Fat, Genomic Imprinting and the Warm Inner Glow , 2008, Current Biology.

[43]  Pumin Zhang,et al.  The Notch Signaling Pathway Controls the Size of the Ocular Lens by Directly Suppressing p57Kip2 Expression , 2007, Molecular and Cellular Biology.

[44]  G. Pinto,et al.  11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Russell-Silver syndrome: clinical scoring system and epigenetic-phenotypic correlations. , 2007, The Journal of clinical endocrinology and metabolism.

[45]  B. Barres,et al.  A Crucial Role for p57Kip2 in the Intracellular Timer that Controls Oligodendrocyte Differentiation , 2007, The Journal of Neuroscience.

[46]  M. Surani,et al.  Cdkn1c (p57Kip2) is the major regulator of embryonic growth within its imprinted domain on mouse distal chromosome 7 , 2007, BMC Developmental Biology.

[47]  Pumin Zhang,et al.  p57 and Hes1 coordinate cell cycle exit with self-renewal of pancreatic progenitors. , 2006, Developmental biology.

[48]  T. Eggermann,et al.  The centromeric 11p15 imprinting centre is also involved in Silver–Russell syndrome , 2006, Journal of Medical Genetics.

[49]  L. Giudice,et al.  IVF results in de novo DNA methylation and histone methylation at an Igf2-H19 imprinting epigenetic switch. , 2005, Molecular human reproduction.

[50]  T. Eggermann,et al.  Is maternal duplication of 11p15 associated with Silver-Russell syndrome? , 2005, Journal of Medical Genetics.

[51]  G. Shaw,et al.  Genomic imprinting of IGF2, p57 KIP2 and PEG1/MEST in a marsupial, the tammar wallaby , 2005, Mechanisms of Development.

[52]  B. Joseph,et al.  p57Kip2 cooperates with Nurr1 in developing dopamine cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[53]  B. Kerr,et al.  Duplications of chromosome 11p15 of maternal origin result in a phenotype that includes growth retardation , 2002, Human Genetics.

[54]  A. Ferguson-Smith,et al.  Dynamic temporal and spatial regulation of the cdk inhibitor p57kip2 during embryo morphogenesis , 2001, Mechanisms of Development.

[55]  G. Vardon,et al.  Maturation of baseline breathing and of hypercapnic and hypoxic ventilatory responses in newborn mice. , 2001, American journal of physiology. Regulatory, integrative and comparative physiology.

[56]  Barbara D. Saatkamp,et al.  Distinct Transcriptional Profiles of Adipogenesisin Vivo and in Vitro * , 2001, The Journal of Biological Chemistry.

[57]  M. Surani,et al.  Distant cis-elements regulate imprinted expression of the mouse p57( Kip2) (Cdkn1c) gene: implications for the human disorder, Beckwith--Wiedemann syndrome. , 2001, Human molecular genetics.

[58]  N. Kanayama,et al.  p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts. , 2000, Molecular human reproduction.

[59]  C. Cepko,et al.  p57(Kip2) regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina. , 2000, Development.

[60]  M. Leibovitch,et al.  Stabilization of MyoD by Direct Binding to p57Kip2 * , 2000, The Journal of Biological Chemistry.

[61]  M. Leibovitch,et al.  Dimerization of the amino terminal domain of p57Kip2 inhibits cyclin D1-Cdk4 kinase activity , 2000, Oncogene.

[62]  M. Surani,et al.  A human p57(KIP2) transgene is not activated by passage through the maternal mouse germline. , 1999, Human molecular genetics.

[63]  M. Leibovitch,et al.  p57Kip2 Stabilizes the MyoD Protein by Inhibiting Cyclin E-Cdk2 Kinase Activity in Growing Myoblasts , 1999, Molecular and Cellular Biology.

[64]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[65]  S. Elledge,et al.  Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome , 1997, Nature.

[66]  M. Barbacid,et al.  Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. , 1997, Genes & development.

[67]  P. Puigserver,et al.  In vitro and in vivo induction of brown adipocyte uncoupling protein (thermogenin) by retinoic acid. , 1996, The Biochemical journal.

[68]  Y. Fukushima,et al.  Genomic imprinting of human p57KIP2 and its reduced expression in Wilms' tumors. , 1996, Human molecular genetics.

[69]  T. Mukai,et al.  Genomic imprinting of p57KIP2, a cyclin–dependent kinase inhibitor, in mouse , 1995, Nature Genetics.

[70]  S. Elledge,et al.  p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene. , 1995, Genes & development.

[71]  J. Massagué,et al.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. , 1995, Genes & development.

[72]  F. Villarroya,et al.  A Novel Regulatory Pathway of Brown Fat Thermogenesis , 1995, The Journal of Biological Chemistry.

[73]  C. Azcona,et al.  Hypoglycaemia and Russell-Silver Syndrome , 2005, Journal of pediatric endocrinology & metabolism : JPEM.

[74]  B. Spiegelman,et al.  Characterization of the novel brown adipocyte cell line HIB 1B. Adrenergic pathways involved in regulation of uncoupling protein gene expression. , 1994, Journal of cell science.